Literature DB >> 33814852

The Positive Predictive Values of the Breast Imaging Reporting and Data System (BI-RADS) 4 Lesions and its Mammographic Morphological Features.

Suvendu Kumar Mohapatra1, Abhisek Mishra2, Tapan Kumar Sahoo3, Rashmita Binod Nayak4, Prafulla Kumar Das5, Bhagyalaxmi Nayak6.   

Abstract

The Breast Imaging Reporting and Data System (BI-RADS) is a comprehensive guideline to systematize breast imaging reporting, and as per its recommendations, any lesion with likelihoods of malignancy greater than 2% is deemed as suspicious and tissue diagnosis is recommended. The aim of the study is to determine the positive predictive value (PPV) of BI-RADS categories 4a, 4b, and 4c for malignancy and association of mammographic morphological features of BI-RADS 4 subgroups with malignant outcomes. We retrospectively reviewed all the patients undergoing mammography with BI-RADS score of 4 followed by biopsy from May 2019 to April 2020. The predictive values of BI-RADS 4 subcategories and morphological features with malignancy are performed taking histopathology report as the gold standard. The PPV of BI-RADS subcategories 4a, 4b, and 4c for malignancies were 34, 89, and 97%, respectively. BI-RADS 4c patients tend to be older (50.2 ± 12.2 vs. 44.6 ± 10.3 years) with larger mass (44 ± 16 vs. 32.9 ± 16.8 mm) at presentation than 4a. Postmenopausal state (P = 0.03) and older age (P = 0.019) were significantly associated with malignancy. There is no meaningful difference observed in the predictability of BI-RADS category 4c lesions among different breast density patterns. The overall higher PPV for BI-RADS 4a and 4b reflects subjectivity in subcategory assignments of BI-RADS 4. In patients, less than 40 years with the BI-RADS 4a category on mammograms may undergo supplementary imaging with MRI which may downscale the lesion classification in turn reducing unnecessary biopsy and surgery. © Indian Association of Surgical Oncology 2021.

Entities:  

Keywords:  BI-RADS 4; Malignancy; Mammography; Morphology; Positive predictive value

Year:  2021        PMID: 33814852      PMCID: PMC7960818          DOI: 10.1007/s13193-020-01274-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  16 in total

1.  Breast cancer screening for women aged 40-49 years: screening may not be the benign process usually thought.

Authors:  M Retsky; R Demicheli; W Hrushesky
Journal:  J Natl Cancer Inst       Date:  2001-10-17       Impact factor: 13.506

2.  Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions.

Authors:  Cholatip Wiratkapun; Weeraya Bunyapaiboonsri; Bussanee Wibulpolprasert; Panuwat Lertsithichai
Journal:  J Med Assoc Thai       Date:  2010-07

3.  BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.

Authors:  Elizabeth Lazarus; Martha B Mainiero; Barbara Schepps; Susan L Koelliker; Linda S Livingston
Journal:  Radiology       Date:  2006-03-28       Impact factor: 11.105

4.  Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.

Authors:  Kevin Strobel; Simone Schrading; Nienke L Hansen; Alexandra Barabasch; Christiane K Kuhl
Journal:  Radiology       Date:  2014-09-29       Impact factor: 11.105

5.  Clinical outcome of breast cancer BI-RADS 4 lesions during 2003-2008 in the National Cancer Institute Thailand.

Authors:  Arkom Chaiwerawattana; Somchai Thanasitthichai; Sarawan Boonlikit; Chanin Apiwanich; Suvipapan Worawattanakul; Anothai Intakawin; Supattra Rakiad; Kanchana Thongkham
Journal:  Asian Pac J Cancer Prev       Date:  2012

6.  Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours.

Authors:  Anne M Bosch; Alfons G H Kessels; Geerard L Beets; Jan D Rupa; Dick Koster; Jos M A van Engelshoven; Maarten F von Meyenfeldt
Journal:  Eur J Radiol       Date:  2003-12       Impact factor: 3.528

7.  Calcium oxalate is associated with benign breast tissue. Can we avoid biopsy?

Authors:  J S Winston; I T Yeh; K Evers; A K Friedman
Journal:  Am J Clin Pathol       Date:  1993-11       Impact factor: 2.493

8.  Comparison of clinicopathological findings among patients whose mammography results were classified as category 4 subgroups of the BI-RADS.

Authors:  Ihsan Metin Leblebici; Suleyman Bozkurt; Turgut Tunc Eren; Ibrahim Ali Ozemir; Julide Sagiroglu; Orhan Alimoglu
Journal:  North Clin Istanb       Date:  2014-08-03

9.  Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention.

Authors:  Chris I Flowers; Cristina O'Donoghue; Dan Moore; Adeline Goss; Danny Kim; June-Ho Kim; Sjoerd G Elias; Julia Fridland; Laura J Esserman
Journal:  Breast Cancer Res Treat       Date:  2013-06-14       Impact factor: 4.872

10.  Mammographic density and structural features can individually and jointly contribute to breast cancer risk assessment in mammography screening: a case-control study.

Authors:  Rikke Rass Winkel; My von Euler-Chelpin; Mads Nielsen; Kersten Petersen; Martin Lillholm; Michael Bachmann Nielsen; Elsebeth Lynge; Wei Yao Uldall; Ilse Vejborg
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.